Global Ovarian Cancer Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 1962

Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer.
North America dominates the global market for ovarian cancer due to large number of aging population. Asia is expected to show high growth rates in the next five years in the global ovarian cancer market. China and India are expected to be the fastest growing ovarian cancer markets in Asia-Pacific region. Some of the key driving forces for ovarian cancer market in emerging countries are rise in healthcare expenditure, large pool of patients and rising government funding.
In 2018, the global Ovarian Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Ovarian Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ovarian Cancer development in United States, Europe and China.

The key players covered in this study
Bristol Myers Squibb
Eli Lilly
GlaxoSmithKline
Janssen Pharmaceuticals
Novogen
Genentech
Aetera Zenteris
Boehringer Ingelheim
Roche

Market segment by Type, the product can be split into
Surgery
Chemotherapy
Radiation
Biological Therapy

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Ovarian Cancer status, future forecast, growth opportunity, key market and key players.
To present the Ovarian Cancer development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Ovarian Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Ovarian Cancer Market Size Growth Rate by Type (2014-2025)
1.4.2 Surgery
1.4.3 Chemotherapy
1.4.4 Radiation
1.4.5 Biological Therapy
1.5 Market by Application
1.5.1 Global Ovarian Cancer Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Ovarian Cancer Market Size
2.2 Ovarian Cancer Growth Trends by Regions
2.2.1 Ovarian Cancer Market Size by Regions (2014-2025)
2.2.2 Ovarian Cancer Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Ovarian Cancer Market Size by Manufacturers
3.1.1 Global Ovarian Cancer Revenue by Manufacturers (2014-2019)
3.1.2 Global Ovarian Cancer Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Ovarian Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Ovarian Cancer Key Players Head office and Area Served
3.3 Key Players Ovarian Cancer Product/Solution/Service
3.4 Date of Enter into Ovarian Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Ovarian Cancer Market Size by Type (2014-2019)
4.2 Global Ovarian Cancer Market Size by Application (2014-2019)

5 United States
5.1 United States Ovarian Cancer Market Size (2014-2019)
5.2 Ovarian Cancer Key Players in United States
5.3 United States Ovarian Cancer Market Size by Type
5.4 United States Ovarian Cancer Market Size by Application

6 Europe
6.1 Europe Ovarian Cancer Market Size (2014-2019)
6.2 Ovarian Cancer Key Players in Europe
6.3 Europe Ovarian Cancer Market Size by Type
6.4 Europe Ovarian Cancer Market Size by Application

7 China
7.1 China Ovarian Cancer Market Size (2014-2019)
7.2 Ovarian Cancer Key Players in China
7.3 China Ovarian Cancer Market Size by Type
7.4 China Ovarian Cancer Market Size by Application

8 Japan
8.1 Japan Ovarian Cancer Market Size (2014-2019)
8.2 Ovarian Cancer Key Players in Japan
8.3 Japan Ovarian Cancer Market Size by Type
8.4 Japan Ovarian Cancer Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Ovarian Cancer Market Size (2014-2019)
9.2 Ovarian Cancer Key Players in Southeast Asia
9.3 Southeast Asia Ovarian Cancer Market Size by Type
9.4 Southeast Asia Ovarian Cancer Market Size by Application

10 India
10.1 India Ovarian Cancer Market Size (2014-2019)
10.2 Ovarian Cancer Key Players in India
10.3 India Ovarian Cancer Market Size by Type
10.4 India Ovarian Cancer Market Size by Application

11 Central & South America
11.1 Central & South America Ovarian Cancer Market Size (2014-2019)
11.2 Ovarian Cancer Key Players in Central & South America
11.3 Central & South America Ovarian Cancer Market Size by Type
11.4 Central & South America Ovarian Cancer Market Size by Application

12 International Players Profiles
12.1 Bristol Myers Squibb
12.1.1 Bristol Myers Squibb Company Details
12.1.2 Company Description and Business Overview
12.1.3 Ovarian Cancer Introduction
12.1.4 Bristol Myers Squibb Revenue in Ovarian Cancer Business (2014-2019)
12.1.5 Bristol Myers Squibb Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Ovarian Cancer Introduction
12.2.4 Eli Lilly Revenue in Ovarian Cancer Business (2014-2019)
12.2.5 Eli Lilly Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Ovarian Cancer Introduction
12.3.4 GlaxoSmithKline Revenue in Ovarian Cancer Business (2014-2019)
12.3.5 GlaxoSmithKline Recent Development
12.4 Janssen Pharmaceuticals
12.4.1 Janssen Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Ovarian Cancer Introduction
12.4.4 Janssen Pharmaceuticals Revenue in Ovarian Cancer Business (2014-2019)
12.4.5 Janssen Pharmaceuticals Recent Development
12.5 Novogen
12.5.1 Novogen Company Details
12.5.2 Company Description and Business Overview
12.5.3 Ovarian Cancer Introduction
12.5.4 Novogen Revenue in Ovarian Cancer Business (2014-2019)
12.5.5 Novogen Recent Development
12.6 Genentech
12.6.1 Genentech Company Details
12.6.2 Company Description and Business Overview
12.6.3 Ovarian Cancer Introduction
12.6.4 Genentech Revenue in Ovarian Cancer Business (2014-2019)
12.6.5 Genentech Recent Development
12.7 Aetera Zenteris
12.7.1 Aetera Zenteris Company Details
12.7.2 Company Description and Business Overview
12.7.3 Ovarian Cancer Introduction
12.7.4 Aetera Zenteris Revenue in Ovarian Cancer Business (2014-2019)
12.7.5 Aetera Zenteris Recent Development
12.8 Boehringer Ingelheim
12.8.1 Boehringer Ingelheim Company Details
12.8.2 Company Description and Business Overview
12.8.3 Ovarian Cancer Introduction
12.8.4 Boehringer Ingelheim Revenue in Ovarian Cancer Business (2014-2019)
12.8.5 Boehringer Ingelheim Recent Development
12.9 Roche
12.9.1 Roche Company Details
12.9.2 Company Description and Business Overview
12.9.3 Ovarian Cancer Introduction
12.9.4 Roche Revenue in Ovarian Cancer Business (2014-2019)
12.9.5 Roche Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details